FDA Approves New Twice-Yearly HIV Prevention Shot: What You Need to Know
Introduction In June 2025, the FDA cleared a major breakthrough in HIV prevention. Gilead’s new drug lenacapavir, branded Yeztugo, is now authorised as a twice-yearly injection (shot) for pre-publicity prophylaxis.